Business
Companies
AMP Capital raises $575m from sale of EY Centre stake
Investors in AMP Capital’s managed office fund have been given a $575 million windfall with the sale of its stake in the skyscraper at 200 George St, Sydney.
- by Carolyn Cummins
Latest
Sector to Base: Atari’s Space Invaders HQ finds new owner
Sector Property Group has snapped up the 1980s home of computer game maker Atari for $24.5 million.
- by Nicole Lindsay
Hub overcomes diversity challenge with striking architecture
Melbourne’s new community hub is a beacon on busy Springvale Road.
- by Stephen Crafti
Ancient sites, rainbow serpents raise risks for Australian miners
Sacred indigenous sites, endangered sawfish and Aboriginal rainbow serpents are the latest challenges confronting Australia as its top mining companies meet for their biggest annual conference.
- by James Thornhill
Fast food, fast delivery, double lane and contact free: KFC and Macca’s new world
Fast-food operators are tweaking the look and location of their outlets amid a seismic shift in customer behaviour.
- by Tim Boreham
Origin Energy takes a $2.2b hit as green shift hurts, coal costs bite
One of Australia’s top utilities has slashed the value of its business as the influx of renewables guts electricity prices and coal power’s profits.
- by Nick Toscano
Opinion
Sharemarket
Big Tech has outgrown this planet
The already bonkers dollars of tech’s Titanic 5 have become even bonkerser. Maybe that’s why Amazon chief Jeff Bezos wanted to touch outer space.
- by Shira Ovide
‘Reality has set in’: COVID treatments a challenge for local industry
Eighteen months on from the start of the COVID-19 pandemic, diagnostics have been a bigger success for Aussie biotechs than finding treatments.
- by Emma Koehn
Ryan Stokes named Boral chair, Seven ups board presence
Seven Group chief executive Ryan Stokes is the new Boral chairman, while the Stokes family investment vehicle has upped its board representation to two after claiming a 70 per cent stake in the company.
- by Alex Druce
Analysis
Coronavirus pandemic
How AstraZeneca’s dream of vaccinating the world fell apart
The damage caused by European leaders launching scathing attacks on AstraZeneca is now becoming clear and has the company weighing up whether it wants a future in vaccines at all.
- by Hannah Boland
‘Wellness company’: Big Tobacco’s move into pharmaceuticals raises eyebrows
Philip Morris says a shift to pharma paves the way to a healthier future, but critics argue it’s no place for cigarette makers.
- by Oliver Gill